Clinical Trials Logo

Craniopharyngioma, Child clinical trials

View clinical trials related to Craniopharyngioma, Child.

Filter by:
  • None
  • Page 1

NCT ID: NCT05465174 Recruiting - Craniopharyngioma Clinical Trials

Nivolumab and DAY101 for Treatment of Craniopharyngioma in Children and Young Adults

PNOC029
Start date: September 12, 2022
Phase: Phase 2
Study type: Interventional

The current study assesses the tolerability and efficacy of combination therapy with PD-1 (nivolumab) and pan-RAF-kinase (DAY101) inhibition for the treatment of children and young adults with craniopharyngioma.

NCT ID: NCT03610906 Enrolling by invitation - Clinical trials for Craniopharyngioma, Child

Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy

Start date: March 12, 2019
Phase:
Study type: Observational

New data suggests that the current treatment for pediatric adamantinomatous craniopharyngioma (CPA) may not be as effective as it could be.